About us
Therapeutic focus
Our Platform
Clinical Programs
- NP-MP1
News & Events
Careers
- Vacancies
- Values

Month: June 2022

NanoPhoria is on LinkedIn

Posted on 1 June 202210 February 2026 by Ed Gover

Posted in Uncategorized

Search

Recent Posts

NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform
NanoPhoria Bioscience Awarded €17.5 M From European Innovation Council’s Accelerator Program
NanoPhoria appoints Dr Suman Shirodkar as chair and Prof. Michael Davidson as non-executive member of the Board of Directors
NanoPhoria Bioscience publishes groundbreaking study in major cardiology journal
Alessio Alogna, one of the founders of NanoPhoria, presented our inhalation-based approach to treat HFrEF in a large animal model at the American Heart Association’s annual Scientific Sessions event, which was held this year in Chicago (AHA 2022)

Recent Comments

No comments to show.

Archives

October 2025
February 2025
January 2024
November 2022
June 2022
May 2022

Categories

Uncategorized

Connect with us

Learn more about our company and the science behind our revolutionary technology platform

Terms of use

Privacy Policy

Cookies

© NanoPhoria S.r.l. All rights reserved.
VAT number: 12246020965